Primary sclerosing cholangitis: Therapeutic options and surveillance management

3Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Primary sclerosing cholangitis is a chronic immune-mediated liver disease. Though rare, it poses several clinical concerns for the managing physician. There are currently limited therapeutic options in the management of the condition and weak evidence base behind them. Endoscopic interven-tion is limited to those patients with obstructing stricture-related disease, and even liver transplantation has a risk of disease recurrence. Surveillance for inflammatory bowel disorders, metabolic bone disease, and malignancy is paramount when managing such patients. This article provides an overview of the condition with further focus on current therapeutic options and guidance on surveillance management.

Cite

CITATION STYLE

APA

Kumar, A., Wheatley, D., & Puttanna, A. (2016, June 9). Primary sclerosing cholangitis: Therapeutic options and surveillance management. Clinical Medicine Insights: Gastroenterology. Libertas Academica Ltd. https://doi.org/10.4137/CGast.S38451

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free